Attenuating Effect of Ginkgo biloba Leaves Extract on Liver Fibrosis Induced by Thioacetamide in Mice

Table 1

Plasma ALT, AST, GGT, ALP, total protein, albumin, glucose, triglycerides, cholesterol, HDL-L, and LDL-C levels (mean ± SD) of control, TAA, TTA plus G. biloba leaves extract, and G. biloba leaves extract treated mice (𝑛 = 7). Percentage changes are included in parentheses.

Parameters	Treatments
	Control	TAA	TAA + leaves extract	Leaves extract
ALT (U/L)	26.63±2.06	58.00±12.15^ab	33.63 ± 6.35^ac	24.75±3.01
		(+117.8)	(+26.9)	(−7.1)
AST (U/L)	41.38±5.10	83.50±23.40^ab	49.87 ± 11.64	41.00±5.93
		(+101.8)	(+20.5)	(−0.9)
GGT (U/L)	4.79±0.55	11.55±1.31^ab	5.83 ± 1.33^c	4.54±0.48
		(+141.1)	(+21.7)	(−5.2)
ALP (U/L)	118.56±8.70	182.63±25.28^ab	127.38 ± 17.78	119.13±8.86
		(+54.0)	(+7.4)	(+0.5)
Total protein (g/dL)	5.67±0.29	4.63±0.30^ab	5.36 ± 0.67	5.63±0.23
		(−18.3)	(−5.5)	(−0.7)
Albumin (g/dL)	3.69±0.31	2.87±0.36^ab	3.30 ± 0.55	3.71±0.29
		(−22.2)	(−10.6)	(+0.5)
Glucose (mg/dL)	85.43±6.90	69.57±8.06^ab	76.14 ± 6.87^c	86.00±6.09
		(−18.6)	(−10.9)	(+0.7)
Triglycerides (mg/dL)	70.00±4.44	136.14 ± 16.38^ab	99.14 ± 17.7^ac	70.85±5.34
		(+94.5)	(+41.6)	(+1.2)
Cholesterol (mg/dL)	92.43±6.16	176.29±35.68^ab	139.29 ± 29.23^ac	94.00±9.93
		(+90.7)	(+50.7)	(+1.7)
HDL-C (mg/dL)	40.75±2.27	32.00±3.06^ab	38.14 ± 2.0^a	39.86±2.80
		(−21.5)	(−6.4)	(−2.2)
LDL-C (mg/dL)	24.86±2.28	46.14±7.20^ab	33.57 ± 3.82^ac	22.75±2.12
		(+85.6)	(+35.0)	(−8.5)

^aIndicates a significant difference between control and treated groups.
^bIndicates a significant difference between the group treated with TAA and groups treated with TAA plus G. biloba leaves extract and G. biloba leaves extract.
^cIndicates a significant difference between the group treated with TAA plus G. biloba leaves extract and group treated with G. biloba leaves extract.